[
  {
    "ts": "2026-01-06T12:01:00+00:00",
    "headline": "MAVIRET® receives Health Canada Approval for the Treatment of Acute Hepatitis C Virus",
    "summary": "AbbVie (NYSE: ABBV) announced today that Health Canada has approved MAVIRET (glecaprevir/pibrentasvir tablets) for the treatment of acute and chronic hepatitis C virus (HCV) infection in adults and pediatric patients 3 years of age and older and weighing ≥ 12 kg.2 It is the first and only oral eight-week pan-genotypic treatment option approved in Canada.",
    "url": "https://finance.yahoo.com/news/maviret-receives-health-canada-approval-120100386.html",
    "source": "CNW Group",
    "provider": "yfinance",
    "raw": {
      "id": "87a355c5-4951-3545-93ab-c2a19df40bf3",
      "content": {
        "id": "87a355c5-4951-3545-93ab-c2a19df40bf3",
        "contentType": "STORY",
        "title": "MAVIRET® receives Health Canada Approval for the Treatment of Acute Hepatitis C Virus",
        "description": "",
        "summary": "AbbVie (NYSE: ABBV) announced today that Health Canada has approved MAVIRET (glecaprevir/pibrentasvir tablets) for the treatment of acute and chronic hepatitis C virus (HCV) infection in adults and pediatric patients 3 years of age and older and weighing ≥ 12 kg.2 It is the first and only oral eight-week pan-genotypic treatment option approved in Canada.",
        "pubDate": "2026-01-06T12:01:00Z",
        "displayTime": "2026-01-06T12:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/cnwgroup.com/9410b8813b5d72821c036bf3b4cb3798",
          "originalWidth": 400,
          "originalHeight": 123,
          "caption": "AbbVie Canada (CNW Group/AbbVie Canada)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Fi.TMFt9yP3uLI.rjcyWJA--~B/aD0xMjM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cnwgroup.com/9410b8813b5d72821c036bf3b4cb3798.cf.webp",
              "width": 400,
              "height": 123,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SN0j3_nLIaagjMmUj0Kb2g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cnwgroup.com/9410b8813b5d72821c036bf3b4cb3798.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "CNW Group",
          "url": "http://www.newswire.ca/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/maviret-receives-health-canada-approval-120100386.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/maviret-receives-health-canada-approval-120100386.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]